Evidence‑Based Management of Status Asthmaticus

Initial Assessment and Triage

Inability to speak full sentences, use of accessory muscles or intercostal retractions, altered mental status, and a PaCO₂ ≥ 42 mm Hg are clinical signs that predict severe airflow obstruction and impending respiratory failure in patients with status asthmaticus. 1
Objective severity should be quantified with peak expiratory flow (PEF) or FEV₁, pulse oximetry, and arterial blood gas analysis when distress is severe or when FEV₁/PEF is < 25 % of predicted. 1

Nebulized albuterol 2.5–5 mg every 20 minutes for three doses, then 2.5–10 mg every 1–4 hours as needed, or continuous nebulization at 10–15 mg/hour for severe cases, markedly reduces emergency‑department length of stay and hospitalization rates when combined with ipratropium and early systemic steroids. 1
Metered‑dose inhaler (MDI) with spacer delivering 4–8 puffs every 20 minutes provides equivalent bronchodilation to nebulized albuterol in mild‑to‑moderate exacerbations when technique is correct. 1

Adding ipratropium bromide to albuterol in the emergency department further shortens ED time and lowers admission rates. 1

All patients with acute severe asthma should receive systemic corticosteroids (oral prednisone, IV methylprednisolone, or dexamethasone) as early as possible; clinical benefits become evident within 6–12 hours. 1

Reassess patients 60–90 minutes after the first three bronchodilator doses; the clinical response at this point is a stronger predictor of the need for hospitalization than the initial severity assessment. Repeat subjective evaluation, physical examination, and FEV₁/PEF measurement. 1

Conditionally recommended for life‑threatening exacerbations or for patients who remain severe after one hour of intensive conventional therapy; no benefit is seen in lower‑severity attacks. 1

Do not delay intubation when any of the following are present: inability to speak full sentences, altered mental status, worsening fatigue despite optimal therapy, or PaCO₂ ≥ 42 mm Hg. Prompt intubation improves outcomes. 1

Methylxanthines (theophylline)
Chest physiotherapy
Mucolytic agents
Sedation outside the context of mechanical ventilation
Aggressive intravenous hydration in older children and adults (may be appropriate only for infants/young children with dehydration)

After stabilization, transition patients to controller medications: inhaled corticosteroids, a long‑acting β₂‑agonist, and a long‑acting muscarinic antagonist.
Consider adding a leukotriene receptor antagonist (e.g., montelukast) while noting the FDA boxed warning issued in March 2020. 2

Delaying systemic corticosteroids—early administration is critical because benefits require 6–12 hours to appear. 1
Continuing ipratropium bromide after emergency‑department stabilization—its benefits are not sustained after admission. 1
Postponing intubation when respiratory failure is imminent—delay worsens outcomes. 1
Providing insufficient expiratory time during mechanical ventilation, which can cause dynamic hyperinflation and barotrauma. 1
Relying solely on subjective clinical judgment; objective measures (PEF, FEV₁, pulse oximetry) should guide decisions. 1